The upregulation of TGM3 in HCC was demonstrated to make a similar contribution to the pathogenesis of HCC as was shown for its downregulation in head and neck squamous cell carcinoma, esophageal, and colorectal cancer. This evidence concerns the gene TGM3 and head and neck squamous cell carcinoma.